Report updated Apr 16, 2026

Overview · Full Intel report in progress

Diagnosaurus® DDx is an established medical app that is completely free. With a 4.8/5 rating from 2.5K reviews, it shows polarized user reception.

What is Diagnosaurus® DDx?

Diagnosaurus® DDx is a medical reference tool designed to assist healthcare professionals with differential diagnosis at the point of care. The app provides a searchable database of over 1,000 diagnoses organized by organ system, symptom, or disease to facilitate clinical decision-making.

Current Momentum

v1.13 · 1w ago

Intense

Last updated 7d ago. 5 versions tracked.

AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Competition

Rivals identification in progress

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

MedicalGrossing

Rating Pulse 🇺🇸

What makes this app unique?

What Does It Look Like?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

Differential Diagnosis DatabaseStandard

Provides access to over 1,000 entries searchable by organ system, symptom, or disease.

See Related DDxStandard

Enables users to link directly to alternative diagnoses within each entry.

Personalization ToolsStandard

Allows users to bookmark entries via a Favorites feature and add custom notes to specific content.

Universal Index SearchStandard

Facilitates rapid navigation across the entire database to locate specific medical information.

How much does it cost?

Free

Who Built It?

Unbound Medicine

(34.9K)

Equipping healthcare professionals with evidence-based clinical decision support and integrated reference tools at the point of care.

Portfolio

13

Apps

Free 12
Medical100%

Who is Unbound Medicine?

Unbound Medicine has established a defensible position by pivoting from standalone medical utilities to integrated clinical suites that consolidate multiple peer-reviewed references into a single workflow. Their primary moat is a network of high-prestige institutional partnerships, including Johns Hopkins Medicine and the American Academy of Pediatrics, which provides a level of authoritative credibility difficult for pure-tech competitors to replicate. The recent acquisition by MPS Limited marks a strategic inflection point, signaling an move toward international expansion and the integration of AI-driven tools into their existing evidence-based platform.

Who is Unbound Medicine for?

  • Professional nurses
  • Physicians
  • Medical students
  • Researchers requiring mobile access to peer-reviewed clinical data
Intense

Portfolio momentum

With 92 releases across 53 active apps in the last 6 months, the publisher maintains an exceptionally high update cadence for its clinical databases.

Last release · 13d agoActive apps · 53

Analysis in progress, available soon

What do users think recently?

Analysis in progress, available soon

Analysis in progress, available soon

What is the competitive landscape for Diagnosaurus® DDx?

How's The Medical Market?

Market outlook for this category

Available very soon

Strategic analysis coming soon

SWOT, key takeaways & outlook

The outtake for Diagnosaurus® DDx

Key Takeaways

The app serves as a quick-reference clinical aid for practitioners to explore potential diagnoses based on patient symptoms.

Where Is It Heading?

Trend analysis

Available very soon

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by Diagnosaurus® DDx, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. “Diagnosaurus® DDx Intelligence Report.” Updated Apr 16, 2026. https://marlvel.ai/intel-report/medical/diagnosaurus-ddx

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0